News
Updates on activities and accomplishments at AYOXXA
As a young and dynamic company determined to anticipate and respond to customer needs, we continue to achieve milestones, bring novel products to market, expand our partnerships, and explore use of our LUNARIS™ technology in new research areas. Follow these developments here.
Conferences
Meet AYOXXA
AYOXXA @ ARVO Annual Meeting 2019
Over 12,000 experts are convening in Vancouver, Canada, for the Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO), the world’s largest international eye and vision conference.
Read more
Meet AYOXXA
AYOXXA @ 13th World Immune Regulation Meeting
Hosted in beautiful Davos, Switzerland, the internationally renowned World Immune Regulation Meeting (WIRM) brings together around 600 scientists from all over the world to discuss the latest findings in immunology, from immune activation and effector functions to immune tolerance and autoimmunity.
Read more
Meet AYOXXA
AYOXXA @ 14th Annual Biomarkers Congress 2019 in Manchester
AYOXXA introduces its innovative LUNARIS™ technology to senior level attendees representing global pharmaceutical organizations, leading biotech companies and internationally renowned academic institutions, all working in the biomarker space across multiple therapeutic areas worldwide.
Read morePress Reviews
Press Review
Multi-cytokine profiles inform treatment decisions
Proteomics is an indispensable tool to elucidate disease etiology. Understanding the molecular background of a disease enables the development of more effective drugs and precise, reliable diagnostics.
Read more
Press Review
June Cover Story: Deep Tech
With AYOXXA cited as one of "the hottest Southeast Asian startups in Biotech", this article is telling the story of co-founders Andreas Schmidt & Dieter Trau: From first conceptual ideas to groundbreaking technology platform and growing AYOXXA into a young, innovative Biotech company.
Read more
Press Review
Translational proteomics at clinical scale
Proteomics is an indispensable methodology for advancing our understanding of disease etiology and the process of drug development, particularly in the post-genome era. Today, researchers often analyze entire protein networks and translate the knowledge generated from basic research into powerful clinical approaches in medical sciences. To fully explore this complex biology, enabling tools and technologies are vital.
Read morePress Releases
Press Release
AYOXXA launches LUNARIS™ Human and Mouse Chemokine Kits to explore chemokine signaling
AYOXXA Biosystems GmbH, an international biotechnology company offering a range of products and services which enable advances in translational proteomics, today announces the expansion of its catalogue of kits for fully scalable multiplex protein analysis with the introduction of LUNARIS™ Chemokine Kits for exploration of human (Human 11-Plex) and murine (Mouse-12-Plex) chemokine signaling pathways.
Read more
Press Release
AYOXXA signs research agreement in the field of ophthalmology with one of the leading pharmaceutical companies
AYOXXA Biosystems GmbH, an international biotechnology company offering a range of products and services which enable advances in translational proteomics, today announced that it has signed a research agreement with one of the leading pharmaceutical companies for the development of a series of low volume, high sensitivity multiplex protein assays intend to validate protein biomarkers in the field of ophthalmology.
Read more
Press Release
AYOXXA launches LUNARIS™ Human & Mouse 6-Plex T Cell Characterization Kits to elucidate T cell differentiation
AYOXXA Biosystems GmbH, an international biotechnology company offering a range of products and services which enable advances in translational proteomics, today announced the expansion of its catalogue of kits for fully scalable multiplex protein analysis with the introduction of LUNARISTM Human & Mouse 6-Plex T Cell Characterization Kits.
Read more